Phase 1 Hepatitis B Trial, Recruiting (NCT06885710)

Phase 1 Hepatitis B Trial, Recruiting NCT06885710 Sponsor: Changhai Hospital Condition: Hepatitis B

Printed from Voxsanity (voxsanity.com.au) — NCT06885710 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis B

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with chronic Hepatitis B infection, shown by a positive HBsAg blood test for at least 6 months
Your blood test for a marker called HBeAg can be either positive or negative — both are accepted
Your genetic tissue type (called HLA type) matches one of three specific types used in this trial (HLA-A*02:01, A*11:01, or A*24:02) — the trial team will check this for you
You have had a liver assessment (such as a biopsy, Fibroscan, or similar test) within the past 6 months showing liver damage consistent with chronic Hepatitis B, but without severe scarring or cirrhosis

Who may not be able to join:

You have a history of another liver disease not related to Hepatitis B, such as iron overload disease, autoimmune hepatitis, alcohol-related liver disease, fatty liver disease, or certain blood disorders
Your liver is not functioning well enough, shown by signs such as fluid build-up in the abdomen or swollen veins in the food pipe, or a specific medical scoring system (Child-Pugh grade B or C)
You have tested positive for HIV
You have been diagnosed with, or are suspected to have, liver cancer — or a blood marker called AFP is above a certain level at screening (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06885710

Sponsor: Changhai Hospital

Phase: Phase 1

Status: Recruiting

Condition: Hepatitis B

More information: https://clinicaltrials.gov/study/NCT06885710

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with chronic Hepatitis B infection, shown by a positive HBsAg blood test for at least 6 months
Your blood test for a marker called HBeAg can be either positive or negative — both are accepted
Your genetic tissue type (called HLA type) matches one of three specific types used in this trial (HLA-A*02:01, A*11:01, or A*24:02) — the trial team will check this for you
You have had a liver assessment (such as a biopsy, Fibroscan, or similar test) within the past 6 months showing liver damage consistent with chronic Hepatitis B, but without severe scarring or cirrhosis

Who may not be able to join:

You have a history of another liver disease not related to Hepatitis B, such as iron overload disease, autoimmune hepatitis, alcohol-related liver disease, fatty liver disease, or certain blood disorders
Your liver is not functioning well enough, shown by signs such as fluid build-up in the abdomen or swollen veins in the food pipe, or a specific medical scoring system (Child-Pugh grade B or C)
You have tested positive for HIV
You have been diagnosed with, or are suspected to have, liver cancer — or a blood marker called AFP is above a certain level at screening (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Changhai Hospital

Registry

ClinicalTrials.gov

Start date

31 December 2024

Est. completion

1 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Assessments of adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov